Menu Search
Equities

Bristol-Myers Squibb Co

BMYS:VIE

Bristol-Myers Squibb Co

Actions
  • Price (--)--
  • Today's Change--
  • Shares traded--
  • 1 Year change--
  • Beta--
--
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Bristol-Myers Squibb Co grew net income 26.84% 6.33bn to 8.03bn despite relatively flat revenue growth.
Gross margin76.18%
Net profit margin-14.04%
Operating margin-11.94%
Return on assets-6.94%
Return on equity-26.70%
Return on investment-9.03%
More ▼

Cash flow in USDView more

In 2023, Bristol-Myers Squibb Co increased its cash reserves by 23.53%, or 2.19bn. The company earned 13.86bn from its operations for a Cash Flow Margin of 30.80%. In addition the company used 2.30bn on investing activities and also paid 9.42bn in financing cash flows.
Cash flow per share1.72
Price/Cash flow per share28.68
Book value per share8.39
Tangible book value per share-16.85
More ▼

Balance sheet in USDView more

Bristol-Myers Squibb Co has a Debt to Total Capital ratio of 75.43%, a lower figure than the previous year's 108.39%.
Current ratio1.16
Quick ratio1.02
Total debt/total equity3.08
Total debt/total capital0.7543
More ▼

Growth rates in USD

SmartText is unavailable
Div yield(5 year avg)3.21%
Div growth rate (5 year)7.34%
Payout ratio (TTM)--
EPS growth(5 years)4.90
EPS (TTM) vs
TTM 1 year ago		-186.74
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.